 |
 |
|
|
|
| Bortezomib |
 |
| Bortezomib |
 |
| 179324-69-7 |
 |
Antineoplastics.
|
 |
Appearance: White or off-white crystalline powder
Identification: (by NMR) The Nuclear Magnetic Resonance spectrum of the sample should be the same as that of reference material
Loss on drying: ¡Â0.5%
Burned ash: ¡Â0.1%
Heavy Metals: ¡Â20ppm
Assay(HPLC): ¡Ã98.5% |
| Industrial field |
pharmaceutical |
|
|
 |
|
|
|
|
|
 |
| There are no existing companies to distribute selected chemical product |
|
 |
|
|
|
